Key result
The ribosome rescue factor PELOTA promotes expression of the longer C/EBPα isoform by directly removing inhibitory unrecycled ribosomes and through indirect effects mediated by mTOR kinase.
Why the study?
Alternative translation initiation controls distinct C/EBP alpha isoforms with opposing effects in myeloid development, but the molecular basis and trans-acting factors governing this start site choice were not fully understood.
The ribosome rescue factor PELO promotes expression of the longer C/EBPα isoform by removing inhibitory unrecycled ribosomes, providing mechanistic insights into translation reinitiation.
Alternative CEBPA translation may shape myeloid differentiation; leaves open isoform-specific targeting in leukemia.
Translation initiation at alternative start sites can dynamically control the synthesis of two or more functionally distinct protein isoforms from a single mRNA. Alternate isoforms of the hematopoietic transcription factor CCAAT-enhancer binding protein α (C/EBP α ) produced from different start sites exert opposing effects during myeloid cell development. This alternative initiation depends on sequence features of the CEBPA transcript, including a regulatory upstream open reading frame (uORF), but the molecular basis is not fully understood. Here we identify trans -acting factors that affect C/EBP α isoform choice using a sensitive and quantitative two-color fluorescence reporter coupled with CRISPRi screening. Our screen uncovered a role for the ribosome rescue factor PELOTA (PELO) in promoting expression of the longer C/EBP α isoform, by directly removing inhibitory unrecycled ribosomes and through indirect effects mediated by the mechanistic target of rapamycin (mTOR) kinase. Our work provides further mechanistic insights into coupling between ribosome recycling and translation reinitiation in regulation of a key transcription factor, with implications for normal hematopoiesis and leukemiagenesis.
No takes yet. Share an insight, caveat, or question.
Fernandez et al. (2023) studied Acute Myeloid Leukemia. PELOTA (PELO) depletion via CRISPRi vs. Nontargeting control sgRNA was evaluated on C/EBPα isoform ratio (measured via dual-color fluorescence reporter). The ribosome rescue factor PELOTA promotes expression of the longer C/EBPα isoform by directly removing inhibitory unrecycled ribosomes and through indirect effects mediated by mTOR kinase.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: